JOHN W KOZARICH

CIK 1223000 · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.42M

Companies

5

Total Filings

90

Lifetime Open-Market Net

-$6.46M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LGND Director 42,622 $255.54 $10.89M -$6.63M 73 2026-06-09
Intec Pharma Ltd. (NTEC) Delisted Director 151,761 $9.63 $1.46M $45.9K 2 2020-07-17
Travere Therapeutics, Inc. (RTRX) Delisted Director 29,000 $0 5 2019-05-10
QLTI Director 57,000 $26.82 $1.53M $115.6K 9 2016-06-21
Corium International, Inc. (CORI) Delisted Director $0 1 2014-12-05

Recent Filings · Page 8 of 9

90 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-07-12 QLTI Grant (A) $0 EDGAR
2012-05-31 LGND Grant (A) +6,517 $0 EDGAR
2011-11-14 LGND Buy (P) +1,000 $11.8K EDGAR
2011-06-03 LGND Grant (A) +7,372 $0 EDGAR
2011-03-03 LGND Buy (P) +5,000 $49.9K EDGAR
2011-02-28 LGND Grant (A) +5,000 $49.9K EDGAR
2011-02-17 LGND Buy (P) +1,000 $9.9K EDGAR
2010-11-12 LGND Buy (P) +10,000 $16.0K EDGAR
2010-05-27 LGND Grant (A) +25,979 $0 EDGAR
2010-05-11 LGND Buy (P) +10,000 $16.8K EDGAR
Showing 7180 of 90
Page 8 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.